User Reviews for Regorafenib
Also known as: Stivarga
Regorafenib has an average rating of 4.4 out of 10 from a total of 7 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 60% reported a negative effect.
|Colorectal Cancer||5 reviews||22 medications|
|Gastrointestinal Stromal Tumor||2 reviews||5 medications|
|Summary of Regorafenib reviews||4.4||7 reviews|
Reviews may be edited to correct grammar/spelling, or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published.
Stivarga (regorafenib) for Colorectal Cancer: “I am writing this as a data point for those who may be considering this drug. My mother was recently put on this and it was literally the worst drug she's ever taken in her 6 year journey battling cancer. I read the reviews and begged her not to take it, but she went through it anyway. The drug caused her to be lethargic to the point where she could not move, she had a severe loss of appetite, she broke out in hives, she lost a significant amount of weight and could barely walk/clothe herself. She literally could not function. She took it for two weeks and by the end of it was so incoherent and weak that she collapsed inside of our home. And this was from taking 2 pills one week, 3 pills the next.”
Stivarga (regorafenib) for Colorectal Cancer: “My husband is going to begin his 3rd month of this med Stivarga on 8/29/20. Dosage is 4 pills a day/160 mg. He takes it on a cycle of 3 weeks on & 1 week off. His side-effects have gotten progressively worse as the 3 week cycle progresses until the point of he can barely function due to lethargy, severe weight loss (he lost 8 lbs in a month) & loss of appetite. Currently he is off medication for 1 week and each day his appetite & energy gets better. I dread 8/29/20 when I know his side-effects are going to return. So far we don't know if this drug is effective on his metastatic stage 4 colon cancer because his Dr hasn't ordered a CT scan yet. Written 8/26/20”
Stivarga (regorafenib) for Colorectal Cancer: “My brother was a father, a brother, a son and a Marine. He was only 53. He was prescribed this drug after radiation and two other chemotherapy drugs had failed. He said the drug utterly robbed him of any energy and made him feel absolutely terrible. Three days after he began treatment, he suffered cardiac arrest while in bed. His wife called an ambulance and they were able to revive him then rush him to the ICU. Unfortunately, the diagnosis was sepsis due to a perforated bowel, which is generally considered unsurvivable. He died there four days later, surrounded by his mother, sister, brother and son. We are heartbroken and horrified at his suffering and will grieve always that he is gone.”
Stivarga (regorafenib) for Colorectal Cancer: “Have taken this medication for over a year. Carcinoembryonic antigen (CEA) well within normal range. Slightly elevated bilirubin. Only side effects are mild to moderate hand foot syndrome, some fatigue and nosebleeds due to low platelets. It is important to note that I have never done IV chemo, so my results may be different from others.”
Stivarga (regorafenib) for Colorectal Cancer: “My husband had liver failure within two weeks of taking this medication, watch your loved one carefully for liver failure signs and symptoms. The warning is serious by the time we saw the MSK doctor for his 2 week blood work, it was already to late there was nothing they could do but send him home on hospice on Christmas Eve he died on January 21 He was a thriving 50 year old, who turned instantly. Unbelievably SAD.”
Stivarga (regorafenib) for Gastrointestinal Stromal Tumor: “Only side effects and no result”
For Gastrointestinal Stromal Tumor: “I have been on stivarga for 18 months. few side effects and tumor has shrunk in half and continues to shrink.”
This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare professionals.
More about regorafenib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: multikinase inhibitors
- Other brands